ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
LianBio Provides Corporate Update and Reports Third Quarter 2021 Financial Results
December 10, 2021LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today provided a corporate update and reported financial results for the third quarter ended September 30, 2021. -
FDA Grants Accelerated Approval to Infigratinib for Metastatic Cholangiocarcinoma
June 04, 2021The FDA granted accelerated approval to infigratinib, a kinase inhibitor for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other ...
Pharma Sources Insight January 2025
